Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Oropharyngeal Neoplasms × Other × Clear all

Phase

Phase NA 2 Phase 2/3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 8 Other 1

Conditions

Obesity 5 Mucositis 4 Stomatitis 3 Dyspnea 3 Polycystic Ovary Syndrome 2 Head and Neck Neoplasms 2 Endometrial Neoplasms 2 Progesterone Resistance 1 Pain 1 Overweight 1 Oropharyngeal Neoplasms 1 Oral Ulcer 1 Opioid-Induced Constipation 1 Neoplasms 1 Motor Activity 1 Lymphoma, Follicular 1 Infertility 1 Hypoxia 1 Fatty Liver 1 Endometrial Hyperplasia 1 Constipation 1 Breast Neoplasms 1 Acidosis, Respiratory 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04648020 2023-05-31

VOICE

Monopar Therapeutics

Phase 2/3 Terminated

Head & NeckOther

Head and Neck Neoplasms, Oropharyngeal Neoplasms, Stomatitis, Oral Ulcer, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡